4503.T
4503.T
JP3942400007
ASTELLAS PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 2.139.245.000.000 1.912.323.000.000
11.9%
Cost of Revenue 408.426.000.000 349.206.000.000
17.0%
Gross Profit 1.730.820.000.000 1.563.117.000.000
10.7%
1.350.761.000.000 1.522.869.000.000
11.3%
Operating Income 380.059.000.000 40.248.000.000
844.3%
Pretax Income 376.587.000.000 31.237.000.000
1105.6%
Net Income Common Stockholders 291.535.000.000 50.747.000.000
474.5%
-- --
--
-- --
--
ende